Cellmid (ASX:CDY) Share Price and News

Market Cap (15-Feb) $12,332,152 (1,885th)	Close (15-Dec) $0.056 0 (0%)	Volume (15-Dec) 0	Shortsold (8-Dec) 13,278 (0.02%) (428th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.024

	Subject
	CDY CDY Ann: Results of Meeting
	1 (current) 2 3
	CDY CDY Ann: AGM Presentation to Shareholders
	CDY CDY Ann: Release of Shares from Voluntary Escrow
	CDY CDY Ann: Cellmid receives R&D tax credit
	CDY CDY Ann: Proposed issue of securities - CDY
	CDY CDY Ann: Letter to Shareholders - Notice of Annual General Meeting
	CDY CDY Ann: Notice of Annual General Meeting/Proxy Form
	CDY CDY Ann: Jobkeeper Payments Notification
	CDY CDY Ann: Initial Director's Interest Notice - Christopher
	CDY CDY Ann: Final Director's Interest Notice - Eck-Thompson
	CDY CDY Ann: Becoming a substantial holder from HNG
	CDY CDY Ann: Appointment of Non-Executive Director
	CDY CDY Ann: Cleansing Notice
	CDY CDY Ann: Application for quotation of securities - CDY
	CDY CDY Ann: BLC Cosmetics Acquisition Completed
	CDY CDY Ann: Results of Meeting
	CDY CDY Ann: General Meeting Presentation
	CDY CDY Ann: Appendix 4C and Quarterly Activity Report
	CDY CDY Ann: Notification of cessation of securities - CDY
	CDY CDY Ann: Investor Webinar
	CDY CDY Ann: Change of Director's Interest Notice - Halasz
	CDY CDY Ann: Letter to Shareholders - Notice of General Meeting
	CDY CDY Ann: Notice of General Meeting/Proxy Form
	CDY CDY Ann: Appendix 4G and Corporate Governance Statement
	CDY CDY Ann: Annual Report to shareholders
	CDY CDY Ann: HNG: BLC Cosmetics to merge with Cellmid
	CDY CDY Ann: Proposed issue of securities - CDY
	CDY CDY Ann: Cellmid to Acquire BLC Cosmetics Pty Ltd
	CDY CDY Ann: Appendix 4E and FY21 Financial Report
	CDY CDY Ann: Appendix 4C and Quarterly Activity Report
	CDY CDY Ann: Notification of cessation of securities - CDY
	CDY CDY Ann: MarketLit Investor Conference Presentation
	CDY CDY Ann: Cellmid Reports Record QVC Sales
	CDY CDY Ann: Release of Shares from Voluntary Escrow
	CDY CDY Ann: FGF5 Inhibitors Supply Agreement - Additional Information
	CDY CDY Ann: Supply Agreement for Cellmid's FGF5 Inhibitors
	CDY CDY Ann: Investor Briefing and Presentation
	CDY CDY Ann: Chinese Import Permits Received
	CDY CDY Ann: Investor Briefing
	CDY CDY Ann: Agreement Signed for Sale of Lyramid Limited
	CDY CDY Ann: Appendix 4C and Quarterly Activity Report
	CDY CDY Ann: Change of Director's Interest Notice - Eck
	CDY CDY Ann: Change of Director's Interest Notice - Cross
	CDY CDY Ann: Change of Director's Interest Notice - Halasz
	CDY CDY Ann: Change of Director's Interest Notice - Gordon
	CDY CDY Ann: CDYOA Top20 and Distribution List
	CDY CDY Ann: Appendix 2A
	CDY CDY Ann: Supplementary Prospectus
	CDY CDY Ann: Proposed issue of Securities - CDY
	CDY CDY Ann: Rights Issue Closed with Strong Demand

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Feb	$0.05	332,060	+0.00 (8.00%)
14-Feb	$0.05	253,069	0.00 (3.85%)
11-Feb	$0.05	173,000	0.00 (0.00%)
10-Feb	$0.05	20,890	+0.00 (4.00%)
09-Feb	$0.05	240,667	+0.00 (2.04%)
08-Feb	$0.05	2,702	0.00 (0.00%)
07-Feb	$0.05	0	0.00 (0.00%)
03-Feb	$0.05	30,000	0.00 (0.00%)
02-Feb	$0.05	190,580	0.00 (3.92%)
01-Feb	$0.05	13,356	+0.00 (4.08%)
31-Jan	$0.05	87,492	0.00 (7.55%)
27-Jan	$0.05	148,608	0.00 (0.00%)
25-Jan	$0.05	77,072	0.00 (1.85%)
24-Jan	$0.05	180,000	0.00 (1.82%)
21-Jan	$0.06	50,143	0.00 (0.00%)
4 up, 5 down, and 6 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
17 May 2025 at 9:10am

High -	Low -	Trades -	Turnover $0	Volume 0
17 May 2025 at 9:10am

Cellmid Health Care
Cancer Medical

$0.056 (0%)

$0.056 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Cellmid Health Care Cancer Medical

$0.056 (0%)

$0.056 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Cellmid Health Care
Cancer Medical